Pesquisar
Aytu Biopharma Inc
AYTUAdicionar à lista de desejos
2.190USD
-0.080-3.52%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
23.51MValor de mercado
PerdaP/L TTM
Mais detalhes de Aytu Biopharma Inc Empresa
Aytu BioPharma, Inc. is a pharmaceutical company focused on commercializing novel therapeutics. The Company's business is focused on its prescription pharmaceutical products sold primarily through third party wholesalers and pharmacies and which primarily consists of two product portfolios. The first consists of two products for the treatment of ADHD: Adzenys XR-ODT (amphetamine) extended-release orally disintegrating tablets (Adzenys) and Cotempla XR-ODT (methylphenidate) extended-release orally disintegrating tablets. The second consists primarily of Karbinal ER (carbinoxamine maleate extended-release oral suspension), an extended-release first-generation antihistamine suspension containing carbinoxamine indicated to treat numerous allergic conditions, and Poly-Vi-Flor and Tri-Vi-Flor, two complementary prescription fluoride-based supplement product lines containing combinations of fluoride and vitamins in various formulations for infants and children with fluoride deficiency.
Informações de Aytu Biopharma Inc
Código da empresaAYTU
Nome da EmpresaAytu Biopharma Inc
Data de listagemOct 20, 2017
CEODisbrow (Joshua R)
Número de funcionários82
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 20
Endereço7900 E. Union Avenue
CidadeDENVER
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal80237
Telefone17204376580
Sitehttps://aytubio.com/
Código da empresaAYTU
Data de listagemOct 20, 2017
CEODisbrow (Joshua R)
Executivos da empresa Aytu Biopharma Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. John A. Donofrio, Jr.
Mr. John A. Donofrio, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Abhinav (Abi) Jian
Mr. Abhinav (Abi) Jian
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Jarrett T. (Josh) Disbrow
Mr. Jarrett T. (Josh) Disbrow
Chief Business Officer
Chief Business Officer
61.57K
+52.15%
Mr. Ryan J. Selhorn, CPA
Mr. Ryan J. Selhorn, CPA
Chief Financial Officer, Treasurer, Corporate Secretary
Chief Financial Officer, Treasurer, Corporate Secretary
49.74K
+67.83%
Mr. Greg Pyszczymuka
Mr. Greg Pyszczymuka
Chief Commercial Officer
Chief Commercial Officer
36.10K
+34.05%
Mr. Carl C. Dockery
Mr. Carl C. Dockery
Independent Director
Independent Director
21.15K
+47.28%
Ms. Vivian H. Liu
Ms. Vivian H. Liu
Independent Director
Independent Director
19.82K
+50.44%
Mr. Joshua R. (Josh) Disbrow
Mr. Joshua R. (Josh) Disbrow
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Detalhamento da receita
Moeda: USDAtualizado em: seg, 6 de abr
Moeda: USDAtualizado em: seg, 6 de abr
FY2026Q2
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
ADHD portfolio
13.22M
87.15%
Pediatric portfolio
1.69M
11.14%
EXXUA
241.00K
1.59%
Other
19.00K
0.13%
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
7.58%
AWM Investment Company, Inc.
5.77%
Lytton (Laurence W)
4.99%
Diadema Partners LP
2.85%
Outro
68.68%
Investidores
Investidores
Proporção
Nantahala Capital Management, LLC
10.13%
Stonepine Capital Management, LLC
7.58%
AWM Investment Company, Inc.
5.77%
Lytton (Laurence W)
4.99%
Diadema Partners LP
2.85%
Outro
68.68%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
16.18%
Hedge Fund
16.10%
Individual Investor
8.98%
Investment Advisor
3.85%
Venture Capital
0.24%
Outro
54.64%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
69
3.87M
36.10%
-493.52K
2025Q4
61
3.62M
34.64%
--
2025Q3
63
3.62M
35.61%
+200.00K
2025Q2
63
3.42M
23.61%
+1.37M
2025Q1
58
1.88M
32.85%
-147.25K
2024Q4
61
1.88M
35.64%
-167.56K
2024Q3
65
2.05M
38.87%
-5.48K
2024Q2
68
2.06M
35.52%
+258.31K
2024Q1
72
1.80M
39.85%
-420.62K
2023Q4
75
1.77M
40.04%
+44.24K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Nantahala Capital Management, LLC
1.09M
10.13%
--
--
Dec 31, 2025
Stonepine Capital Management, LLC
813.70K
7.58%
-78.15K
-8.76%
Dec 31, 2025
AWM Investment Company, Inc.
619.57K
5.77%
--
--
Dec 31, 2025
Lytton (Laurence W)
535.32K
4.99%
+413.25K
+338.56%
Dec 31, 2025
Diadema Partners LP
305.79K
2.85%
+33.12K
+12.15%
Dec 31, 2025
Disbrow (Joshua R.)
207.20K
1.93%
+53.95K
+35.20%
Oct 13, 2025
Two Sigma Investments, LP
149.63K
1.39%
+41.10K
+37.86%
Dec 31, 2025
Persistent Asset Partners Limited
79.42K
0.74%
+16.96K
+27.16%
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Dimensional US Core Equity 1 ETF
0%
DFA Dimensional US Sustainability Core 1 ETF
0%
Dimensional US Core Equity 1 ETF
Proporção0%
DFA Dimensional US Sustainability Core 1 ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Data
Data ex-dividendo
Tipo
Proporção
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Jan 05, 2023
Merger
20→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
Dec 08, 2020
Merger
10→1
